Current Advances in Immune Checkpoint Therapy
Although immune checkpoint inhibitors (ICIs) have shown survival benefits for patients with metastatic cancers, some challenges have been under intense study in recent years. The most critical challenges include the side effects and the emergence of resistance. Potential opportunities exist to devel...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2023
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/84040 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Current Advances in Immune Checkpoint Therapy
- Immune Checkpoint and Tumor Therapy
- Immune Checkpoint Inhibitors for Hepatocellular Carcinoma: Recent Advances
- Gut Microbiota and Immune Checkpoint Inhibitors: A Synergistic Approach in Hepatocellular Carcinoma Therapy
- The Role of Immune Checkpoints in Cancer Progression
- Dendritic Cell–T Cell Crosstalk as a Central Driver of Response and Resistance to Immune Checkpoint Therapies
- Immune and Cell Cycle Checkpoint Inhibitors for Cancer Immunotherapy